These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 33957276)

  • 1. Cellular pathways of recombinant adeno-associated virus production for gene therapy.
    Sha S; Maloney AJ; Katsikis G; Nguyen TNT; Neufeld C; Wolfrum J; Barone PW; Springs SL; Manalis SR; Sinskey AJ; Braatz RD
    Biotechnol Adv; 2021; 49():107764. PubMed ID: 33957276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unravelling the essential elements for recombinant adeno-associated virus (rAAV) production in animal cell-based platforms.
    Catalán-Tatjer D; Tzimou K; Nielsen LK; Lavado-García J
    Biotechnol Adv; 2024; 73():108370. PubMed ID: 38692443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
    Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and purification of recombinant adeno-associated vectors.
    Wang L; Blouin V; Brument N; Bello-Roufai M; Francois A
    Methods Mol Biol; 2011; 807():361-404. PubMed ID: 22034039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The state of technological advancement to address challenges in the manufacture of rAAV gene therapies.
    Destro F; Wu W; Srinivasan P; Joseph J; Bal V; Neufeld C; Wolfrum JM; Manalis SR; Sinskey AJ; Springs SL; Barone PW; Braatz RD
    Biotechnol Adv; 2024 Nov; 76():108433. PubMed ID: 39168354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical challenges and advances in recombinant adeno-associated virus (rAAV) biomanufacturing.
    Fu Q; Polanco A; Lee YS; Yoon S
    Biotechnol Bioeng; 2023 Sep; 120(9):2601-2621. PubMed ID: 37126355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro.
    Yang CC; Xiao X; Zhu X; Ansardi DC; Epstein ND; Frey MR; Matera AG; Samulski RJ
    J Virol; 1997 Dec; 71(12):9231-47. PubMed ID: 9371582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays.
    Buck TM; Wijnholds J
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.
    Chamberlain K; Riyad JM; Weber T
    Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recombinant adeno-associated virus vector related impurities].
    Diao Y; Wang Q; Xiao W; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):717-23. PubMed ID: 21845838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated virus as a delivery vector for gene therapy of human diseases.
    Wang JH; Gessler DJ; Zhan W; Gallagher TL; Gao G
    Signal Transduct Target Ther; 2024 Apr; 9(1):78. PubMed ID: 38565561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular transport of recombinant adeno-associated virus vectors.
    Nonnenmacher M; Weber T
    Gene Ther; 2012 Jun; 19(6):649-58. PubMed ID: 22357511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Popularizing Recombinant Baculovirus-derived OneBac System for Laboratory Production of all Recombinant Adeno-associated Virus Vector Serotypes.
    Wu Y; Han Z; Duan M; Jiang L; Tian T; Jin D; Wang Q; Xu F
    Curr Gene Ther; 2021; 21(2):167-176. PubMed ID: 33461466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular design for recombinant adeno-associated virus (rAAV) vector production.
    Aponte-Ubillus JJ; Barajas D; Peltier J; Bardliving C; Shamlou P; Gold D
    Appl Microbiol Biotechnol; 2018 Feb; 102(3):1045-1054. PubMed ID: 29204900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in upstream process development for production of recombinant adeno-associated virus.
    Ou J; Tang Y; Xu J; Tucci J; Borys MC; Khetan A
    Biotechnol Bioeng; 2024 Jan; 121(1):53-70. PubMed ID: 37691172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors.
    Handa A; Muramatsu SI; Qiu J; Mizukami H; Brown KE
    J Gen Virol; 2000 Aug; 81(Pt 8):2077-2084. PubMed ID: 10900047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative transcriptomic and proteomic kinetic analysis of adeno-associated virus production systems.
    Lin YC; Lu M; Cai W; Hu WS
    Appl Microbiol Biotechnol; 2024 Jun; 108(1):385. PubMed ID: 38896252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding cellular mechanism of recombinant adeno-associated virus (rAAV) and engineering host-cell factories toward intensified viral vector manufacturing.
    Wang Y; Fu Q; Park SY; Lee YS; Park SY; Lee DY; Yoon S
    Biotechnol Adv; 2024; 71():108322. PubMed ID: 38336188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Large-scale production of recombinant adeno-associated virus (rAAV)].
    Wang F; Diao Y; Xiao W; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2009 Nov; 25(11):1608-13. PubMed ID: 20222456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.